From Medscape Diabetes & Endocrinology

Coverage from

Obesity Week 2023

October 14 - 17, 2023; Dallas, Texas

October 14 - 17, 2023 Dallas, Texas
  • Obesity Week 2023 Beyond Semaglutide, a Coming Pipeline of New Antiobesity Meds With nutrient-stimulated hormone therapies for obesity in phase 3 trials, and activin-receptor inhibitors the next upcoming drug class, highly effective treatments for obesity are in sight.
  • Obesity Week 2023 Antidepressants 'Don't Blunt' Semaglutide and Weight Loss Clinicians 'should be reassured' that patients with obesity and on antidepressants who don't have major depressive disorder or suicidality in the past 2 years can receive semaglutide, says a researcher.

Conference News

Medscape Diabetes© 

Popular News From Obesity Week 2022